Key Insights
The United Kingdom diabetes care devices market is experiencing robust growth, projected to reach £84.31 million in 2025 and maintain a Compound Annual Growth Rate (CAGR) of 6.72% from 2025 to 2033. This expansion is driven by several key factors. The rising prevalence of diabetes, particularly type 2 diabetes, within the UK population is a significant driver. Increased awareness of the importance of effective blood glucose monitoring and insulin management, coupled with advancements in device technology, are also contributing to market growth. Specifically, the adoption of continuous glucose monitoring (CGM) systems is accelerating, offering patients improved convenience and better glycemic control. The shift towards tubeless insulin pumps, enhancing patient comfort and usability, further fuels market expansion. While the high cost of advanced technologies like CGMs and insulin pumps might present a restraint, the growing availability of insurance coverage and reimbursement schemes is mitigating this challenge. Furthermore, a growing emphasis on remote patient monitoring and telehealth solutions is likely to further propel market growth in the coming years. The market is segmented by component (insulin pumps, pens, monitoring devices), end-user (hospitals, home care), and technology (tethered vs. tubeless pumps), offering various opportunities for market players.
The competitive landscape is characterized by a mix of established global players and specialized smaller firms. Companies like Medtronic, Abbott Diabetes Care, and Novo Nordisk are major market participants, competing based on their product portfolio, technological innovation, and distribution networks. The UK market's success is also influenced by the government's initiatives to improve diabetes care and management, including funding for advanced technologies and educational programs. The increasing prevalence of diabetes complications such as cardiovascular disease and kidney failure emphasizes the necessity for early diagnosis and consistent management, creating a strong impetus for the continued growth of the UK diabetes care devices market. The regional distribution across England, Wales, Scotland, and Northern Ireland reflects the overall UK diabetes prevalence, with variations potentially driven by local healthcare infrastructure and initiatives. The forecast period (2025-2033) promises significant opportunities for companies offering innovative and cost-effective diabetes care solutions.
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market: A Comprehensive Report (2019-2033)
This comprehensive report provides an in-depth analysis of the United Kingdom (UK) Diabetes Care Devices market, encompassing market dynamics, growth trends, regional dominance, product landscape, challenges, opportunities, and key players. With a study period spanning 2019-2033, a base year of 2025, and a forecast period of 2025-2033, this report offers invaluable insights for industry professionals, investors, and stakeholders. The report analyzes the parent market of Diabetes Care and its child market focusing specifically on Devices, delivering crucial data in million units.
United Kingdom (UK) Diabetes Care Devices Market Dynamics & Structure
The UK diabetes care devices market is characterized by a moderately concentrated landscape, with key players like Terumo, Dexcom, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, and Arkray competing for market share. Market concentration is estimated at xx% in 2025.
- Technological Innovation: Continuous Glucose Monitoring (CGM) and automated insulin delivery (AID) systems are major drivers, pushing market growth towards more sophisticated and convenient solutions. Innovation barriers include high R&D costs and stringent regulatory approvals.
- Regulatory Framework: The UK's National Institute for Health and Care Excellence (NICE) guidelines significantly impact market access and adoption of new devices. Recent updates incorporating CGMs for type 2 diabetic children showcase the evolving regulatory landscape.
- Competitive Product Substitutes: Traditional methods like fingerstick glucose monitoring still exist, but their market share is steadily decreasing due to the convenience and accuracy of CGM systems.
- End-User Demographics: The aging population and rising prevalence of type 1 and type 2 diabetes fuel market growth, with a significant portion of end-users residing in Home/Personal settings.
- M&A Trends: The market has witnessed xx M&A deals in the last five years, primarily focused on expanding product portfolios and enhancing technological capabilities (e.g., Abbott's partnership with CamDiab and Ypsomed).
United Kingdom (UK) Diabetes Care Devices Market Growth Trends & Insights
The UK diabetes care devices market is projected to experience significant growth during the forecast period (2025-2033). Market size is estimated at xx million units in 2025 and is expected to reach xx million units by 2033, exhibiting a CAGR of xx%. This growth is fueled by increasing diabetes prevalence, rising healthcare expenditure, and the adoption of advanced technologies like CGMs and AID systems. Market penetration for CGMs is expected to increase from xx% in 2025 to xx% in 2033. Consumer behavior is shifting towards greater self-management and preference for minimally invasive, user-friendly devices. The increasing awareness about the benefits of early diagnosis and treatment is further contributing to the market growth. Technological disruptions such as the introduction of tubeless insulin pumps are revolutionizing the market, enhancing patient compliance and improving treatment outcomes.
-Diabetes-Care-Devices-Market.png)
Dominant Regions, Countries, or Segments in United Kingdom (UK) Diabetes Care Devices Market
The Home/Personal segment holds the largest market share within the end-user category, driven by the increasing preference for self-monitoring and management of diabetes at home. Within components, Continuous Glucose Monitoring (CGM) devices are witnessing the fastest growth, surpassing self-monitoring blood glucose (SMBG) devices in market share due to superior accuracy and convenience. England is the dominant region within the UK, owing to its larger population and higher prevalence of diabetes.
- Key Drivers:
- Rising prevalence of diabetes
- Increasing healthcare expenditure
- Government initiatives promoting early diagnosis and treatment
- Growing adoption of advanced technologies (CGMs, AID systems)
- Dominance Factors:
- Higher prevalence of diabetes in specific regions (e.g., England)
- Better healthcare infrastructure in urban areas
- Increased awareness and acceptance of advanced technologies
United Kingdom (UK) Diabetes Care Devices Market Product Landscape
The UK diabetes care devices market offers a diverse range of products, including insulin pumps (tethered and tubeless), insulin pens, insulin syringes, jet injectors, SMBG devices, lancets, and CGMs. Product innovation focuses on improving accuracy, reducing invasiveness, and enhancing user experience. Key features include wireless connectivity, data integration with smartphones, and sophisticated algorithms for automated insulin delivery. These advancements offer improved disease management and enhanced patient outcomes.
Key Drivers, Barriers & Challenges in United Kingdom (UK) Diabetes Care Devices Market
Key Drivers: Technological advancements (CGMs, AID systems), rising diabetes prevalence, government initiatives to improve diabetes care, and increasing healthcare spending. For instance, NICE guidelines for CGM adoption are accelerating market growth.
Challenges & Restraints: High device costs, limited access to advanced technologies in certain regions, reimbursement challenges, and regulatory hurdles impacting market entry of new devices. Supply chain disruptions caused by the COVID-19 pandemic also pose a challenge. The market impact of these factors is estimated at a xx% reduction in overall growth during 2020-2022.
Emerging Opportunities in United Kingdom (UK) Diabetes Care Devices Market
Emerging opportunities include the growth of telehealth and remote patient monitoring, expansion into underserved populations, development of integrated diabetes management solutions, and personalized medicine approaches. The increasing demand for user-friendly, wearable devices presents significant growth potential.
Growth Accelerators in the United Kingdom (UK) Diabetes Care Devices Market Industry
Long-term growth will be driven by technological breakthroughs in AI-powered insulin delivery, advanced CGM sensors with improved accuracy and longer wear times, and the development of closed-loop systems for automated insulin delivery. Strategic partnerships between device manufacturers and healthcare providers will also play a crucial role in market expansion and adoption.
Key Players Shaping the United Kingdom (UK) Diabetes Care Devices Market Market
- Terumo
- Dexcom
- Insulin Devices
- Roche Diabetes Care
- Eli Lilly
- Sanofi
- Abbott Diabetes Care
- Medtronic
- LifeScan (Johnson & Johnson)
- Becton Dickinson
- Novo Nordisk A/S
- Arkray
Notable Milestones in United Kingdom (UK) Diabetes Care Devices Market Sector
- May 2023: NICE guidelines revision incorporating CGMs for type 2 diabetic children. This significantly boosts CGM adoption and market growth.
- April 2022: Abbott, CamDiab, and Ypsomed partnership to develop an integrated automated insulin delivery (AID) system, highlighting collaborative efforts to enhance market offerings.
In-Depth United Kingdom (UK) Diabetes Care Devices Market Outlook
The future of the UK diabetes care devices market is bright, driven by continuous technological advancements, a growing diabetic population, and supportive government policies. Strategic partnerships and market expansions into underserved areas will unlock substantial growth potential. The increasing focus on personalized medicine and AI-powered solutions will further shape market dynamics in the coming years. The market is expected to witness a substantial increase in adoption of advanced technologies, leading to improved patient outcomes and a healthier diabetic population.
United Kingdom (UK) Diabetes Care Devices Market Segmentation
-
1. Management Devices
-
1.1. Insulin Pump
-
1.1.1. Technology
- 1.1.1.1. Tethered Insulin Pump
- 1.1.1.2. Tubeless Insulin Pump
-
1.1.2. Component
- 1.1.2.1. Insulin Pump Device
- 1.1.2.2. Insulin Pump Reservoir
- 1.1.2.3. Infusion Set
-
1.1.1. Technology
-
1.2. Insulin pens
- 1.2.1. Cartridges in Reusable Pens
- 1.2.2. Insulin Disposable Pens
- 1.3. Insulin Syringes
- 1.4. Jet Injectors
-
1.1. Insulin Pump
-
2. Monitoring Devices
-
2.1. Self-monitoring Blood Glucose
- 2.1.1. Glucometer Devices
- 2.1.2. Blood Glucose Test Strips
- 2.1.3. Lancets
-
2.2. Continuous Glucose Monitoring
- 2.2.1. Sensors
- 2.2.2. Durables (Receivers and Transmitters)
-
2.1. Self-monitoring Blood Glucose
-
3. End User
- 3.1. Hospital/Clinics
- 3.2. Home/Personal
United Kingdom (UK) Diabetes Care Devices Market Segmentation By Geography
- 1. United Kingdom
-Diabetes-Care-Devices-Market.png)
United Kingdom (UK) Diabetes Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.72% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment
- 3.3. Market Restrains
- 3.3.1. High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework
- 3.4. Market Trends
- 3.4.1. Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 5.1.1. Insulin Pump
- 5.1.1.1. Technology
- 5.1.1.1.1. Tethered Insulin Pump
- 5.1.1.1.2. Tubeless Insulin Pump
- 5.1.1.2. Component
- 5.1.1.2.1. Insulin Pump Device
- 5.1.1.2.2. Insulin Pump Reservoir
- 5.1.1.2.3. Infusion Set
- 5.1.1.1. Technology
- 5.1.2. Insulin pens
- 5.1.2.1. Cartridges in Reusable Pens
- 5.1.2.2. Insulin Disposable Pens
- 5.1.3. Insulin Syringes
- 5.1.4. Jet Injectors
- 5.1.1. Insulin Pump
- 5.2. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.2.1. Self-monitoring Blood Glucose
- 5.2.1.1. Glucometer Devices
- 5.2.1.2. Blood Glucose Test Strips
- 5.2.1.3. Lancets
- 5.2.2. Continuous Glucose Monitoring
- 5.2.2.1. Sensors
- 5.2.2.2. Durables (Receivers and Transmitters)
- 5.2.1. Self-monitoring Blood Glucose
- 5.3. Market Analysis, Insights and Forecast - by End User
- 5.3.1. Hospital/Clinics
- 5.3.2. Home/Personal
- 5.4. Market Analysis, Insights and Forecast - by Region
- 5.4.1. United Kingdom
- 5.1. Market Analysis, Insights and Forecast - by Management Devices
- 6. England United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7. Wales United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8. Scotland United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9. Northern United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10. Ireland United Kingdom (UK) Diabetes Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11. Competitive Analysis
- 11.1. Market Share Analysis 2024
- 11.2. Company Profiles
- 11.2.1 Terumo
- 11.2.1.1. Overview
- 11.2.1.2. Products
- 11.2.1.3. SWOT Analysis
- 11.2.1.4. Recent Developments
- 11.2.1.5. Financials (Based on Availability)
- 11.2.2 Dexcom
- 11.2.2.1. Overview
- 11.2.2.2. Products
- 11.2.2.3. SWOT Analysis
- 11.2.2.4. Recent Developments
- 11.2.2.5. Financials (Based on Availability)
- 11.2.3 Insulin Devices
- 11.2.3.1. Overview
- 11.2.3.2. Products
- 11.2.3.3. SWOT Analysis
- 11.2.3.4. Recent Developments
- 11.2.3.5. Financials (Based on Availability)
- 11.2.4 Roche Diabetes Care
- 11.2.4.1. Overview
- 11.2.4.2. Products
- 11.2.4.3. SWOT Analysis
- 11.2.4.4. Recent Developments
- 11.2.4.5. Financials (Based on Availability)
- 11.2.5 Eli Lilly
- 11.2.5.1. Overview
- 11.2.5.2. Products
- 11.2.5.3. SWOT Analysis
- 11.2.5.4. Recent Developments
- 11.2.5.5. Financials (Based on Availability)
- 11.2.6 Sanofi
- 11.2.6.1. Overview
- 11.2.6.2. Products
- 11.2.6.3. SWOT Analysis
- 11.2.6.4. Recent Developments
- 11.2.6.5. Financials (Based on Availability)
- 11.2.7 Abbott Diabetes Care
- 11.2.7.1. Overview
- 11.2.7.2. Products
- 11.2.7.3. SWOT Analysis
- 11.2.7.4. Recent Developments
- 11.2.7.5. Financials (Based on Availability)
- 11.2.8 Medtronic
- 11.2.8.1. Overview
- 11.2.8.2. Products
- 11.2.8.3. SWOT Analysis
- 11.2.8.4. Recent Developments
- 11.2.8.5. Financials (Based on Availability)
- 11.2.9 LifeScan (Johnson & Johnson)
- 11.2.9.1. Overview
- 11.2.9.2. Products
- 11.2.9.3. SWOT Analysis
- 11.2.9.4. Recent Developments
- 11.2.9.5. Financials (Based on Availability)
- 11.2.10 Becton Dickinson
- 11.2.10.1. Overview
- 11.2.10.2. Products
- 11.2.10.3. SWOT Analysis
- 11.2.10.4. Recent Developments
- 11.2.10.5. Financials (Based on Availability)
- 11.2.11 Novo Nordisk A/S
- 11.2.11.1. Overview
- 11.2.11.2. Products
- 11.2.11.3. SWOT Analysis
- 11.2.11.4. Recent Developments
- 11.2.11.5. Financials (Based on Availability)
- 11.2.12 Arkray
- 11.2.12.1. Overview
- 11.2.12.2. Products
- 11.2.12.3. SWOT Analysis
- 11.2.12.4. Recent Developments
- 11.2.12.5. Financials (Based on Availability)
- 11.2.1 Terumo
List of Figures
- Figure 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: United Kingdom (UK) Diabetes Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 3: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 5: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 6: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 7: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2019 & 2032
- Table 8: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2019 & 2032
- Table 9: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 10: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Region 2019 & 2032
- Table 11: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 12: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Country 2019 & 2032
- Table 13: England United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 14: England United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 15: Wales United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 16: Wales United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 17: Scotland United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 18: Scotland United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 19: Northern United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 20: Northern United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 21: Ireland United Kingdom (UK) Diabetes Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 22: Ireland United Kingdom (UK) Diabetes Care Devices Market Volume (K Unit) Forecast, by Application 2019 & 2032
- Table 23: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 24: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Management Devices 2019 & 2032
- Table 25: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Monitoring Devices 2019 & 2032
- Table 27: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by End User 2019 & 2032
- Table 28: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by End User 2019 & 2032
- Table 29: United Kingdom (UK) Diabetes Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 30: United Kingdom (UK) Diabetes Care Devices Market Volume K Unit Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the United Kingdom (UK) Diabetes Care Devices Market?
The projected CAGR is approximately 6.72%.
2. Which companies are prominent players in the United Kingdom (UK) Diabetes Care Devices Market?
Key companies in the market include Terumo, Dexcom, Insulin Devices, Roche Diabetes Care, Eli Lilly, Sanofi, Abbott Diabetes Care, Medtronic, LifeScan (Johnson & Johnson), Becton Dickinson, Novo Nordisk A/S, Arkray.
3. What are the main segments of the United Kingdom (UK) Diabetes Care Devices Market?
The market segments include Management Devices, Monitoring Devices, End User.
4. Can you provide details about the market size?
The market size is estimated to be USD 84.31 Million as of 2022.
5. What are some drivers contributing to market growth?
Rising Prevalence of Cancer Worldwide; Technological Advancements in Diagnostic Testing; Increasing Demand for Point-of-care Treatment.
6. What are the notable trends driving market growth?
Continuous Glucose Monitoring Segment is Expected to Witness a Healthy Growth Rate Over the Forecast Period.
7. Are there any restraints impacting market growth?
High Cost of Molecular Diagnostic Tests; Lack of Skilled Workforce and Stringent Regulatory Framework.
8. Can you provide examples of recent developments in the market?
May 2023: The National Institute of Clinical Excellence (NICE) made a significant advancement by revising its guidelines to incorporate CGMs and flash glucose monitors, which are automated glucose monitoring devices, for children diagnosed with type 2 diabetes. This development marks a significant milestone for the United Kingdom, as it eliminates the sole reliance on fingerstick testing to monitor blood sugar levels in children. Although fingersticks have been valuable, they can induce stress and discomfort, particularly for children and their families who need to perform numerous tests daily.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 3800, USD 4500, and USD 5800 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million and volume, measured in K Unit.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "United Kingdom (UK) Diabetes Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the United Kingdom (UK) Diabetes Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the United Kingdom (UK) Diabetes Care Devices Market?
To stay informed about further developments, trends, and reports in the United Kingdom (UK) Diabetes Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
